Insulet has launched its Omnipod 5 automated insulin delivery system (Omnipod 5) in the UK.
Omnipod 5 is indicated for use in type 1 diabetes patients aged two years and above.
It can integrate with a continuous glucose monitor to manage blood sugar without multiple daily injections and zero finger sticks.
The device is claimed to be the first CE-marked tubeless hybrid closed loop system that can be integrated with the Dexcom G6 Continuous Glucose Monitoring (CGM) System for adjusting insulin delivery automatically, offering protection against high and low levels of glucose.
